BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This clinical investigation is being performed to compare the effect of BOL-303259-X dosed once daily (QD) with timolol maleate 0.5% dosed twice daily (BID) in reducing intraocular pressure (IOP) measured over a 24-hour period in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Epistemonikos ID: 3b8d14d7bf892991d8d642ab5f992bbbd77e105c
First added on: May 11, 2024